Legg-Calve-Perthes DiseaseNCT05840146
Kineesiotaping for Patients With LCPD
A study testing Kinesiotaping in people with Legg-Calve-Perthes Disease, run by Istanbul University - Cerrahpasa at 1 site in Turkey (Türkiye).
Trial summary
Kinesiotaping is increasingly being used as a complement to musculoskeletal pain management. This study aimed to evaluate the immediate clinical efficacy of kinesiotaping on pain and pain-related symptoms of Legg-Calvé-Perthes Disease (LCPD). Read more about this study
- Who is it for?
- Ages 5 to 18 years
- Conditions the study is for
- Legg-Calve-Perthes Disease
- What is being tested?
- Kinesiotaping
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 30 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 25 Sep 2017to 11 Jan 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 5 to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- Having received unilateral LCPD diagnosis,
- Anterior hip pain minimum three points on 10-cm Visual Analog Scale (VAS) over the previous week,
- Having the following symptoms; weakness of gluteus medius muscle and patient-reported complaints on function or balance
Who cannot join
- Having a history of any other hip pathologies,
- Having allergy to polyacrylate adhesive,
- Having used analgesic medication within the previous three days.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effects of Kinesiotaping in Patients With Legg-Calvé-Perthes Disease: A Randomized, Double-blind, Placebo-controlled Trial
Kinesiotaping is increasingly being used as a complement to musculoskeletal pain management. This study aimed to evaluate the immediate clinical efficacy of kinesiotaping on pain and pain-related symptoms of Legg-Calvé-Perthes Disease (LCPD).
Read the detailed description
Kinesio taping is increasingly being used as a complement to musculoskeletal pain management. A randomized, double-blind, placebo-controlled clinical trial was conducted. Activity-related hip pain, passive and pain limited hip range of motion, gluteus medius muscle strength, function and balance were assessed.
- Conditions
- Legg-Calve-Perthes Disease
- Being tested
- Kinesiotaping, Sham taping
- Keywords
- Kinesiotape, Taping, Pediatric pain, Hip joint, Physiotherapy
- Medical subject headings
- Legg-Calve-Perthes Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
KinesiotapingOther
Two I-strips were used:
- The first-third of one I-strip began at the posterior iliac crest, without tension as an anchor. Then the patient actively flexed and adducted the affected hip, thus, the middle-third of the tape was applied with approximately 50% tension. Then the hip was set in its original position and the last-third of the tape ended approximately greater trochanter without tension.
- The first-third of the second I-strip was applied starting at the anterior iliac crest, without tension as an anchor. The patient actively extended and adducted the affected hip, thus, the middle-third of the tape was applied with approximately 50% tension. Then the hip was set in its original position and the last-third of the tape ended approximately greater trochanter without tension.
Sham tapingOther
A single I-strip without tension in tape or muscle stretch. After paper backing was completely removed, tape was essentially placed on the skin across the lateral side of the hip.
| Study group | Role | What they receive |
|---|---|---|
| Kinesiotaping group | Experimental | Kinesiotape was applied to the lateral side of the affected hip for gluteus medius muscle. Each patient was positioned lying down with the affected side up, and two I-strips were used. Receives: Other: Kinesiotaping |
| Sham taping group | Sham comparator | Sham tape was applied with a single I-strip without tension in tape or muscle stretch. After paper backing was completely removed, tape was essentially placed on the skin across the lateral side of the affected hip. Receives: Other: Sham taping |
What is being measured
The primary outcome is the main question the study is designed to answer.
Immediate Clinical Efficacy on Activity Related Hip
Horizontal 10 cm VAS (0, no pain; 10, the worst pain ever possible)
Measured: The change between T1 (baseline) to T2 (thirty minutes later from the application)
Secondary outcomes (4)
Immediate Clinical Efficacy on Hip Abduction ROM
goniometric range of motion (ROM)
Measured: The change between T1 (baseline) to T2 (thirty minutes later from the application)
Immediate Clinical Efficacy on Functional Task Durations
10-meters walk task duration (sec) and 10-step climbing task duration (sec)
Measured: The change between T1 (baseline) to T2 (thirty minutes later from the application)
Immediate Clinical Efficacy on Balance test durations
One leg stance test duration (sec) and Tandem walk test duration (sec)
Measured: The change between T1 (baseline) to T2 (thirty minutes later from the application)
Immediate Clinical Efficacy on Gluteus medius muscle strength
muscle strength by handheld dynamometer (Ibs)
Measured: The change between T1 (baseline) to T2 (thirty minutes later from the application)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 May 2023
- Study start25 Sep 2017
- Primary completion6 Apr 2020
- Study completion11 Jan 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Legg-Calve-Perthes DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Istanbul University - Cerrahpasa
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Sezen Karaborklu Argut, Istanbul University - Cerrahpasa
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05840146
- Sponsor's protocol ID
- 20151704-1746
- Status last verified
- Apr 2023
- First submitted
- 20 Mar 2023
- Last updated
- 3 May 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 May 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Kinesiotaping in Patients With Legg-Calvé-Perthes Disease: A Randomized, Double-blind, Placebo-controlled Trial
- ClinicalTrials.gov ID
- NCT05840146
- Acronym / sponsor ID
- 20151704-1746
- Conditions
- Legg-Calve-Perthes Disease
- Keywords
- Kinesiotape, Taping, Pediatric pain, Hip joint, Physiotherapy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Istanbul University - CerrahpasaUniversity, hospital or other
- Study start
- 25 Sep 2017 (actual)
- Primary completion
- 6 Apr 2020 (actual)
- Study completion
- 11 Jan 2021 (actual)
- First posted
- 3 May 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Kinesiotaping is increasingly being used as a complement to musculoskeletal pain management. This study aimed to evaluate the immediate clinical efficacy of kinesiotaping on pain and pain-related symptoms of Legg-Calvé-Perthes Disease (LCPD).
Detailed description
Kinesio taping is increasingly being used as a complement to musculoskeletal pain management. A randomized, double-blind, placebo-controlled clinical trial was conducted. Activity-related hip pain, passive and pain limited hip range of motion, gluteus medius muscle strength, function and balance were assessed.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Kinesiotaping group | Experimental | Other: KinesiotapingKinesiotape was applied to the lateral side of the affected hip for gluteus medius muscle. Each patient was positioned lying down with the affected side up, and two I-strips were used. |
| Sham taping group | Sham comparator | Other: Sham tapingSham tape was applied with a single I-strip without tension in tape or muscle stretch. After paper backing was completely removed, tape was essentially placed on the skin across the lateral side of the affected hip. |
Who may qualify
- Ages
- 5 to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (3 listed)
- Having received unilateral LCPD diagnosis,
- Anterior hip pain minimum three points on 10-cm Visual Analog Scale (VAS) over the previous week,
- Having the following symptoms; weakness of gluteus medius muscle and patient-reported complaints on function or balance
Key exclusion criteria (3 listed)
- Having a history of any other hip pathologies,
- Having allergy to polyacrylate adhesive,
- Having used analgesic medication within the previous three days.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| KinesiotapingTwo I-strips were used: 1. The first-third of one I-strip began at the posterior iliac crest, without tension as an anchor. Then the patient actively flexed and adducted the affected hip, thus, the middle-third of the tape was applied with approximately 50% tension. Then the hip was set in its original position and the last-third of the tape ended approximately greater trochanter without tension. 2. The first-third of the second I-strip was applied starting at the anterior iliac crest, without tension as an anchor. The patient actively extended and adducted the affected hip, thus, the middle-third of the tape was applied with approximately 50% tension. Then the hip was set in its original position and the last-third of the tape ended approximately greater trochanter without tension. | Other | Kinesiotaping group |
| Sham tapingA single I-strip without tension in tape or muscle stretch. After paper backing was completely removed, tape was essentially placed on the skin across the lateral side of the hip. | Other | Sham taping group |
Primary outcome
Immediate Clinical Efficacy on Activity Related Hip
Time frame: The change between T1 (baseline) to T2 (thirty minutes later from the application)
Horizontal 10 cm VAS (0, no pain; 10, the worst pain ever possible)
4 secondary outcomes
Immediate Clinical Efficacy on Hip Abduction ROM
Time frame: The change between T1 (baseline) to T2 (thirty minutes later from the application)
Immediate Clinical Efficacy on Functional Task Durations
Time frame: The change between T1 (baseline) to T2 (thirty minutes later from the application)
Immediate Clinical Efficacy on Balance test durations
Time frame: The change between T1 (baseline) to T2 (thirty minutes later from the application)
Immediate Clinical Efficacy on Gluteus medius muscle strength
Time frame: The change between T1 (baseline) to T2 (thirty minutes later from the application)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 May 2023.
Related trials for Legg-Calve-Perthes Disease
Recruiting
Autologous Bone Marrow Aspirate Treatment for Early-Stage Osteonecrosis
Osteonecrosis of the Femoral Head, Avascular Necrosis of the Femoral Head
Active, not recruiting
Early Feasibility Study of Cartilage Defect Repair
Osteoarthritis, Hip, Femoroacetabular Impingement
RecruitingPhase 2
Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
Sickle Cell Disease, Sickle Cell Anemia
RecruitingObservational study
Screening for Biomarkers of Osteonecrosis of the Femoral Head
Osteonecrosis of the Femoral Head
Active, not recruitingPhase 2
A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage Osteonecrosis of the Femoral Head
Osteonecrosis, Osteonecrosis of the Femoral Head
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Kinesiotaping in people with Legg-Calve-Perthes Disease, run by Istanbul University - Cerrahpasa at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 May 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Immediate Clinical Efficacy on Activity Related Hip (time frame: The change between T1 (baseline) to T2 (thirty minutes later from the application)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 May 2023; AzTrials last refreshed its copy on 27 Oct 2026.